These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10931191)

  • 1. Highly potent inhibitors of human cathepsin L identified by screening combinatorial pentapeptide amide collections.
    Brinker A; Weber E; Stoll D; Voigt J; Müller A; Sewald N; Jung G; Wiesmüller KH; Bohley P
    Eur J Biochem; 2000 Aug; 267(16):5085-92. PubMed ID: 10931191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of noncovalent inhibitors of human cathepsin L. From the 96-residue proregion to optimized tripeptides.
    Chowdhury SF; Sivaraman J; Wang J; Devanathan G; Lachance P; Qi H; Ménard R; Lefebvre J; Konishi Y; Cygler M; Sulea T; Purisima EO
    J Med Chem; 2002 Nov; 45(24):5321-9. PubMed ID: 12431059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding pockets on the surface of human leukocyte elastase and human leukocyte cathepsin G. Implications to the design of inhibitors derived from human C-reactive protein.
    Yavin EJ; Eisenstein M; Fridkin M
    Biomed Pept Proteins Nucleic Acids; 1996-1997; 2(3):71-8. PubMed ID: 9575343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotin-labelled peptidyl diazomethane inhibitors derived from the substrate-like sequence of cystatin: targeting of the active site of cruzipain, the major cysteine proteinase of Trypanosoma cruzi.
    Lalmanach G; Mayer R; Serveau C; Scharfstein J; Gauthier F
    Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):395-9. PubMed ID: 8809025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New chemotypes for cathepsin K inhibitors.
    Teno N; Irie O; Miyake T; Gohda K; Horiuchi M; Tada S; Nonomura K; Kometani M; Iwasaki G; Betschart C
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2599-603. PubMed ID: 18375120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epoxysuccinyl peptide-derived cathepsin B inhibitors: modulating membrane permeability by conjugation with the C-terminal heptapeptide segment of penetratin.
    Schaschke N; Deluca D; Assfalg-Machleidt I; Höhneke C; Sommerhoff CP; Machleidt W
    Biol Chem; 2002 May; 383(5):849-52. PubMed ID: 12108551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptidyl vinyl sulphones: a new class of potent and selective cysteine protease inhibitors: S2P2 specificity of human cathepsin O2 in comparison with cathepsins S and L.
    Brömme D; Klaus JL; Okamoto K; Rasnick D; Palmer JT
    Biochem J; 1996 Apr; 315 ( Pt 1)(Pt 1):85-9. PubMed ID: 8670136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinity selection to papain yields potent peptide inhibitors of cathepsins L, B, H, and K.
    Bratkovic T; Lunder M; Popovic T; Kreft S; Turk B; Strukelj B; Urleb U
    Biochem Biophys Res Commun; 2005 Jul; 332(3):897-903. PubMed ID: 15913550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cathepsin L by epoxysuccinyl peptides simultaneously addressing active-site and remote-site regions.
    Schaschke N; Assfalg-Machleidt I; Machleidt W
    Chembiochem; 2008 Jul; 9(11):1721-4. PubMed ID: 18551692
    [No Abstract]   [Full Text] [Related]  

  • 10. Arylamine based cathepsin K inhibitors: investigating P3 heterocyclic substituents.
    Shinozuka T; Shimada K; Matsui S; Yamane T; Ama M; Fukuda T; Taki M; Takeda Y; Otsuka E; Yamato M; Naito S
    Bioorg Med Chem; 2006 Oct; 14(20):6807-19. PubMed ID: 16829073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L.
    Falgueyret JP; Oballa RM; Okamoto O; Wesolowski G; Aubin Y; Rydzewski RM; Prasit P; Riendeau D; Rodan SB; Percival MD
    J Med Chem; 2001 Jan; 44(1):94-104. PubMed ID: 11141092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of new peptide amides as selective cathepsin L inhibitors: the first step towards selective irreversible inhibitors?
    Torkar A; Lenarčič B; Lah T; Dive V; Devel L
    Bioorg Med Chem Lett; 2013 May; 23(10):2968-73. PubMed ID: 23562595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 1.
    Liu H; Tully DC; Epple R; Bursulaya B; Li J; Harris JL; Williams JA; Russo R; Tumanut C; Roberts MJ; Alper PB; He Y; Karanewsky DS
    Bioorg Med Chem Lett; 2005 Nov; 15(22):4979-84. PubMed ID: 16183279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct properties of prohormone thiol protease (PTP) compared to cathepsins B, L, and H: evidence for PTP as a novel cysteine protease.
    Azaryan AV; Hook VY
    Arch Biochem Biophys; 1994 Oct; 314(1):171-7. PubMed ID: 7944391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure based development of novel specific inhibitors for cathepsin L and cathepsin S in vitro and in vivo.
    Katunuma N; Murata E; Kakegawa H; Matsui A; Tsuzuki H; Tsuge H; Turk D; Turk V; Fukushima M; Tada Y; Asao T
    FEBS Lett; 1999 Sep; 458(1):6-10. PubMed ID: 10518923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hybrids of chicken cystatin with human kininogen domain 2 sequences exhibit novel inhibition of calpain, improved inhibition of actinidin and impaired inhibition of papain, cathepsin L and cathepsin B.
    Auerswald EA; Nägler DK; Gross S; Assfalg-Machleidt I; Stubbs MT; Eckerskorn C; Machleidt W; Fritz H
    Eur J Biochem; 1996 Feb; 235(3):534-42. PubMed ID: 8654398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New ligands for HLA DRB1*0301 by random selection of favourable amino acids ranked by competition studies with undecapeptide amide sublibraries.
    Jung C; Kalbus M; Fleckenstein B; Melms A; Jung G; Wiesmüller KH
    J Immunol Methods; 1998 Oct; 219(1-2):139-49. PubMed ID: 9831395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azepanone-based inhibitors of human cathepsin L.
    Marquis RW; James I; Zeng J; Trout RE; Thompson S; Rahman A; Yamashita DS; Xie R; Ru Y; Gress CJ; Blake S; Lark MA; Hwang SM; Tomaszek T; Offen P; Head MS; Cummings MD; Veber DF
    J Med Chem; 2005 Nov; 48(22):6870-8. PubMed ID: 16250645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrate/propeptide-derived endo-epoxysuccinyl peptides as highly potent and selective cathepsin B inhibitors.
    Schaschke N; Assfalg-Machleidt I; Machleidt W; Moroder L
    FEBS Lett; 1998 Jan; 421(1):80-2. PubMed ID: 9462845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azapeptides structurally based upon inhibitory sites of cystatins as potent and selective inhibitors of cysteine proteases.
    Wieczerzak E; Drabik P; Łankiewicz L; Ołdziej S; Grzonka Z; Abrahamson M; Grubb A; Brömme D
    J Med Chem; 2002 Sep; 45(19):4202-11. PubMed ID: 12213061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.